Raphael Pharmaceutical Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RAPH research report →
About the company
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life.
- CEO
- Shlomo Pilo
- IPO
- 2023
- HQ
- Jaffa, IL
Price Chart
- Market Cap
- $28.25M
- P/E
- -25.69
- P/S
- 0.00
- P/B
- -17.00
- EV/EBITDA
- -27.08
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 79.82%
- ROIC
- 62.76%
- Revenue
- $0 · 0.00%
- Net Income
- $-1,279,000 · 15.80%
- EPS
- $-0.07 · 19.56%
- Op Income
- $-1,245,000
- FCF YoY
- 60.53%
- 52W High
- $1.40
- 52W Low
- $0.05
- 50D MA
- $1.40
- 200D MA
- $1.22
- Beta
- 1.90
- Avg Volume
- 109.652
Get TickerSpark's AI analysis on RAPH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 20, 25 | Louria Hayon Igal | other | 350,000 |
| Nov 20, 25 | Louria Hayon Igal | other | 350,000 |
| Aug 1, 25 | Laor Zvi Laufer | other | 0 |
| Mar 10, 25 | Eliya Yehuda | other | 200,000 |
| May 12, 22 | Eliya Yehuda | other | 202,000 |
| Mar 2, 25 | Pilo Shlomo | other | 200,000 |
| Mar 2, 25 | Pilo Shlomo | other | 100,000 |
| Mar 5, 25 | Dhadha Ajay Kumar | other | 350,000 |
| Mar 5, 25 | Dhadha Ajay Kumar | other | 250,000 |
| Jan 8, 25 | Dhadha Ajay Kumar | other | 0 |
Our RAPH coverage
Recent articles, reports, and earnings notes.
No research on RAPH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RAPH report →Similar companies
Peers in the same neighborhood.